CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer

Article

Abstract: The results allowing the Cuban Regulatory Agency (CECMED) to grant the Sanitary Registration to the

Palabras claves:

cancer vaccine, CIMAvax-EGF, Fast-Track registration, NSCLC, Phase II-III clinical trial

Autores:

Arteaga N., Cuevas A., García Verdecia B., González G., Lage Davila A., Neninger Vinageras E., Rodríguez G., Tania Crombet, Viña L.

Fuentes:

scopus